Back to top

Bristol Myers Squibb Stock Trades Above Analyst Target: What BMY's Price Signals Now

Bristol Myers Squibb (BMY) recently traded above its average 12-month analyst price target of $62.77, signaling potential market optimism. Analyst ratings remain mixed but generally positive, with price target ranges reflecting uncertainties in revenue, pipeline, and valuation prospects.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bristol Myers Squibb Company (BMY)